Geographic Atrophy Market, Global Outlook and Forecast 2024-2031

Report ID: 1641638 | Published Date: Jan 2025 | No. of Page: 63 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Geographic Atrophy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Geographic Atrophy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Geographic Atrophy Overall Market Size
    2.1 Global Geographic Atrophy Market Size: 2021 VS 2028
    2.2 Global Geographic Atrophy Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Geographic Atrophy Players in Global Market
    3.2 Top Global Geographic Atrophy Companies Ranked by Revenue
    3.3 Global Geographic Atrophy Revenue by Companies
    3.4 Top 3 and Top 5 Geographic Atrophy Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Geographic Atrophy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Geographic Atrophy Players in Global Market
        3.6.1 List of Global Tier 1 Geographic Atrophy Companies
        3.6.2 List of Global Tier 2 and Tier 3 Geographic Atrophy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Geographic Atrophy Market Size Markets, 2021 & 2028
        4.1.2 Above 60 Years
        4.1.3 Above 75 Years
    4.2 By Type - Global Geographic Atrophy Revenue & Forecasts
        4.2.1 By Type - Global Geographic Atrophy Revenue, 2017-2022
        4.2.2 By Type - Global Geographic Atrophy Revenue, 2023-2028
        4.2.3 By Type - Global Geographic Atrophy Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Geographic Atrophy Market Size, 2021 & 2028
        5.1.2 Late-stage (Phase III)
        5.1.3 Phase II
        5.1.4 Phase I
        5.1.5 Pre-clinical stage
    5.2 By Application - Global Geographic Atrophy Revenue & Forecasts
        5.2.1 By Application - Global Geographic Atrophy Revenue, 2017-2022
        5.2.2 By Application - Global Geographic Atrophy Revenue, 2023-2028
        5.2.3 By Application - Global Geographic Atrophy Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Geographic Atrophy Market Size, 2021 & 2028
    6.2 By Region - Global Geographic Atrophy Revenue & Forecasts
        6.2.1 By Region - Global Geographic Atrophy Revenue, 2017-2022
        6.2.2 By Region - Global Geographic Atrophy Revenue, 2023-2028
        6.2.3 By Region - Global Geographic Atrophy Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Geographic Atrophy Revenue, 2017-2028
        6.3.2 US Geographic Atrophy Market Size, 2017-2028
        6.3.3 Canada Geographic Atrophy Market Size, 2017-2028
        6.3.4 Mexico Geographic Atrophy Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Geographic Atrophy Revenue, 2017-2028
        6.4.2 Germany Geographic Atrophy Market Size, 2017-2028
        6.4.3 France Geographic Atrophy Market Size, 2017-2028
        6.4.4 U.K. Geographic Atrophy Market Size, 2017-2028
        6.4.5 Italy Geographic Atrophy Market Size, 2017-2028
        6.4.6 Russia Geographic Atrophy Market Size, 2017-2028
        6.4.7 Nordic Countries Geographic Atrophy Market Size, 2017-2028
        6.4.8 Benelux Geographic Atrophy Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Geographic Atrophy Revenue, 2017-2028
        6.5.2 China Geographic Atrophy Market Size, 2017-2028
        6.5.3 Japan Geographic Atrophy Market Size, 2017-2028
        6.5.4 South Korea Geographic Atrophy Market Size, 2017-2028
        6.5.5 Southeast Asia Geographic Atrophy Market Size, 2017-2028
        6.5.6 India Geographic Atrophy Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Geographic Atrophy Revenue, 2017-2028
        6.6.2 Brazil Geographic Atrophy Market Size, 2017-2028
        6.6.3 Argentina Geographic Atrophy Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Geographic Atrophy Revenue, 2017-2028
        6.7.2 Turkey Geographic Atrophy Market Size, 2017-2028
        6.7.3 Israel Geographic Atrophy Market Size, 2017-2028
        6.7.4 Saudi Arabia Geographic Atrophy Market Size, 2017-2028
        6.7.5 UAE Geographic Atrophy Market Size, 2017-2028
7 Players Profiles
    7.1 Apellis Pharmaceuticals
        7.1.1 Apellis Pharmaceuticals Corporate Summary
        7.1.2 Apellis Pharmaceuticals Business Overview
        7.1.3 Apellis Pharmaceuticals Geographic Atrophy Major Product Offerings
        7.1.4 Apellis Pharmaceuticals Geographic Atrophy Revenue in Global Market (2017-2022)
        7.1.5 Apellis Pharmaceuticals Key News
    7.2 Iveric Bio
        7.2.1 Iveric Bio Corporate Summary
        7.2.2 Iveric Bio Business Overview
        7.2.3 Iveric Bio Geographic Atrophy Major Product Offerings
        7.2.4 Iveric Bio Geographic Atrophy Revenue in Global Market (2017-2022)
        7.2.5 Iveric Bio Key News
    7.3 Alkeus Pharmaceuticals
        7.3.1 Alkeus Pharmaceuticals Corporate Summary
        7.3.2 Alkeus Pharmaceuticals Business Overview
        7.3.3 Alkeus Pharmaceuticals Geographic Atrophy Major Product Offerings
        7.3.4 Alkeus Pharmaceuticals Geographic Atrophy Revenue in Global Market (2017-2022)
        7.3.5 Alkeus Pharmaceuticals Key News
    7.4 Hemera Biosciences
        7.4.1 Hemera Biosciences Corporate Summary
        7.4.2 Hemera Biosciences Business Overview
        7.4.3 Hemera Biosciences Geographic Atrophy Major Product Offerings
        7.4.4 Hemera Biosciences Geographic Atrophy Revenue in Global Market (2017-2022)
        7.4.5 Hemera Biosciences Key News
    7.5 Allegro Ophthalmics
        7.5.1 Allegro Ophthalmics Corporate Summary
        7.5.2 Allegro Ophthalmics Business Overview
        7.5.3 Allegro Ophthalmics Geographic Atrophy Major Product Offerings
        7.5.4 Allegro Ophthalmics Geographic Atrophy Revenue in Global Market (2017-2022)
        7.5.5 Allegro Ophthalmics Key News
    7.6 Stealth BioTherapeutics
        7.6.1 Stealth BioTherapeutics Corporate Summary
        7.6.2 Stealth BioTherapeutics Business Overview
        7.6.3 Stealth BioTherapeutics Geographic Atrophy Major Product Offerings
        7.6.4 Stealth BioTherapeutics Geographic Atrophy Revenue in Global Market (2017-2022)
        7.6.5 Stealth BioTherapeutics Key News
    7.7 Gyroscope Therapeutics
        7.7.1 Gyroscope Therapeutics Corporate Summary
        7.7.2 Gyroscope Therapeutics Business Overview
        7.7.3 Gyroscope Therapeutics Geographic Atrophy Major Product Offerings
        7.7.4 Gyroscope Therapeutics Geographic Atrophy Revenue in Global Market (2017-2022)
        7.7.5 Gyroscope Therapeutics Key News
    7.8 Regenerative Patch Technologies
        7.8.1 Regenerative Patch Technologies Corporate Summary
        7.8.2 Regenerative Patch Technologies Business Overview
        7.8.3 Regenerative Patch Technologies Geographic Atrophy Major Product Offerings
        7.8.4 Regenerative Patch Technologies Geographic Atrophy Revenue in Global Market (2017-2022)
        7.8.5 Regenerative Patch Technologies Key News
    7.9 Roche
        7.9.1 Roche Corporate Summary
        7.9.2 Roche Business Overview
        7.9.3 Roche Geographic Atrophy Major Product Offerings
        7.9.4 Roche Geographic Atrophy Revenue in Global Market (2017-2022)
        7.9.5 Roche Key News
    7.10 Gensight Biologics
        7.10.1 Gensight Biologics Corporate Summary
        7.10.2 Gensight Biologics Business Overview
        7.10.3 Gensight Biologics Geographic Atrophy Major Product Offerings
        7.10.4 Gensight Biologics Geographic Atrophy Revenue in Global Market (2017-2022)
        7.10.5 Gensight Biologics Key News
    7.11 NGM Biopharmaceuticals
        7.11.1 NGM Biopharmaceuticals Corporate Summary
        7.11.2 NGM Biopharmaceuticals Business Overview
        7.11.3 NGM Biopharmaceuticals Geographic Atrophy Major Product Offerings
        7.11.4 NGM Biopharmaceuticals Geographic Atrophy Revenue in Global Market (2017-2022)
        7.11.5 NGM Biopharmaceuticals Key News
    7.12 AstraZeneca
        7.12.1 AstraZeneca Corporate Summary
        7.12.2 AstraZeneca Business Overview
        7.12.3 AstraZeneca Geographic Atrophy Major Product Offerings
        7.12.4 AstraZeneca Geographic Atrophy Revenue in Global Market (2017-2022)
        7.12.5 AstraZeneca Key News
    7.13 Lineage Cell Therapeutics
        7.13.1 Lineage Cell Therapeutics Corporate Summary
        7.13.2 Lineage Cell Therapeutics Business Overview
        7.13.3 Lineage Cell Therapeutics Geographic Atrophy Major Product Offerings
        7.13.4 Lineage Cell Therapeutics Geographic Atrophy Revenue in Global Market (2017-2022)
        7.13.5 Lineage Cell Therapeutics Key News
    7.14 Allergan
        7.14.1 Allergan Corporate Summary
        7.14.2 Allergan Business Overview
        7.14.3 Allergan Geographic Atrophy Major Product Offerings
        7.14.4 Allergan Geographic Atrophy Revenue in Global Market (2017-2022)
        7.14.5 Allergan Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Geographic Atrophy Market Opportunities & Trends in Global Market
    Table 2. Geographic Atrophy Market Drivers in Global Market
    Table 3. Geographic Atrophy Market Restraints in Global Market
    Table 4. Key Players of Geographic Atrophy in Global Market
    Table 5. Top Geographic Atrophy Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Geographic Atrophy Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Geographic Atrophy Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Geographic Atrophy Product Type
    Table 9. List of Global Tier 1 Geographic Atrophy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Geographic Atrophy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Geographic Atrophy Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Geographic Atrophy Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Geographic Atrophy Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Geographic Atrophy Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Geographic Atrophy Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Geographic Atrophy Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Geographic Atrophy Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Geographic Atrophy Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Geographic Atrophy Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Geographic Atrophy Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Geographic Atrophy Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Geographic Atrophy Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Geographic Atrophy Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Geographic Atrophy Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Geographic Atrophy Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Geographic Atrophy Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Geographic Atrophy Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Geographic Atrophy Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Geographic Atrophy Revenue, (US$, Mn), 2023-2028
    Table 30. Apellis Pharmaceuticals Corporate Summary
    Table 31. Apellis Pharmaceuticals Geographic Atrophy Product Offerings
    Table 32. Apellis Pharmaceuticals Geographic Atrophy Revenue (US$, Mn), (2017-2022)
    Table 33. Iveric Bio Corporate Summary
    Table 34. Iveric Bio Geographic Atrophy Product Offerings
    Table 35. Iveric Bio Geographic Atrophy Revenue (US$, Mn), (2017-2022)
    Table 36. Alkeus Pharmaceuticals Corporate Summary
    Table 37. Alkeus Pharmaceuticals Geographic Atrophy Product Offerings
    Table 38. Alkeus Pharmaceuticals Geographic Atrophy Revenue (US$, Mn), (2017-2022)
    Table 39. Hemera Biosciences Corporate Summary
    Table 40. Hemera Biosciences Geographic Atrophy Product Offerings
    Table 41. Hemera Biosciences Geographic Atrophy Revenue (US$, Mn), (2017-2022)
    Table 42. Allegro Ophthalmics Corporate Summary
    Table 43. Allegro Ophthalmics Geographic Atrophy Product Offerings
    Table 44. Allegro Ophthalmics Geographic Atrophy Revenue (US$, Mn), (2017-2022)
    Table 45. Stealth BioTherapeutics Corporate Summary
    Table 46. Stealth BioTherapeutics Geographic Atrophy Product Offerings
    Table 47. Stealth BioTherapeutics Geographic Atrophy Revenue (US$, Mn), (2017-2022)
    Table 48. Gyroscope Therapeutics Corporate Summary
    Table 49. Gyroscope Therapeutics Geographic Atrophy Product Offerings
    Table 50. Gyroscope Therapeutics Geographic Atrophy Revenue (US$, Mn), (2017-2022)
    Table 51. Regenerative Patch Technologies Corporate Summary
    Table 52. Regenerative Patch Technologies Geographic Atrophy Product Offerings
    Table 53. Regenerative Patch Technologies Geographic Atrophy Revenue (US$, Mn), (2017-2022)
    Table 54. Roche Corporate Summary
    Table 55. Roche Geographic Atrophy Product Offerings
    Table 56. Roche Geographic Atrophy Revenue (US$, Mn), (2017-2022)
    Table 57. Gensight Biologics Corporate Summary
    Table 58. Gensight Biologics Geographic Atrophy Product Offerings
    Table 59. Gensight Biologics Geographic Atrophy Revenue (US$, Mn), (2017-2022)
    Table 60. NGM Biopharmaceuticals Corporate Summary
    Table 61. NGM Biopharmaceuticals Geographic Atrophy Product Offerings
    Table 62. NGM Biopharmaceuticals Geographic Atrophy Revenue (US$, Mn), (2017-2022)
    Table 63. AstraZeneca Corporate Summary
    Table 64. AstraZeneca Geographic Atrophy Product Offerings
    Table 65. AstraZeneca Geographic Atrophy Revenue (US$, Mn), (2017-2022)
    Table 66. Lineage Cell Therapeutics Corporate Summary
    Table 67. Lineage Cell Therapeutics Geographic Atrophy Product Offerings
    Table 68. Lineage Cell Therapeutics Geographic Atrophy Revenue (US$, Mn), (2017-2022)
    Table 69. Allergan Corporate Summary
    Table 70. Allergan Geographic Atrophy Product Offerings
    Table 71. Allergan Geographic Atrophy Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Geographic Atrophy Segment by Type in 2021
    Figure 2. Geographic Atrophy Segment by Application in 2021
    Figure 3. Global Geographic Atrophy Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Geographic Atrophy Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Geographic Atrophy Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Geographic Atrophy Revenue in 2021
    Figure 8. By Type - Global Geographic Atrophy Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Geographic Atrophy Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Geographic Atrophy Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Geographic Atrophy Revenue Market Share, 2017-2028
    Figure 12. US Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Geographic Atrophy Revenue Market Share, 2017-2028
    Figure 16. Germany Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 17. France Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Geographic Atrophy Revenue Market Share, 2017-2028
    Figure 24. China Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 28. India Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Geographic Atrophy Revenue Market Share, 2017-2028
    Figure 30. Brazil Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Geographic Atrophy Revenue Market Share, 2017-2028
    Figure 33. Turkey Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Geographic Atrophy Revenue, (US$, Mn), 2017-2028
    Figure 37. Apellis Pharmaceuticals Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Iveric Bio Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Alkeus Pharmaceuticals Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Hemera Biosciences Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Allegro Ophthalmics Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Stealth BioTherapeutics Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Gyroscope Therapeutics Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Regenerative Patch Technologies Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Roche Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Gensight Biologics Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. NGM Biopharmaceuticals Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. AstraZeneca Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Lineage Cell Therapeutics Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Allergan Geographic Atrophy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
63
Frequently Asked Questions
Geographic Atrophy Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Geographic Atrophy Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Geographic Atrophy Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Udenafil Market

Udenafil is a new phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction (E ... Read More

Seed Market

A seed is the ripened fertilized ovule of a flowering plant containing an embryo and capable norm ... Read More